Yongzhong Hou

ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 13

Top Venues

Cancer science

Journal of cellular biochemistry

Evidence-based complementary and alternative medicine : eCAM

Oncogene

jiangsu university

Tianjin University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

jiangsu university Jul 10 2012

China

Professor :: School of life sciences

Education History

Tianjin University Feb 20 2002 - Mar 08 2005

China

PHD

Publications

Qian Gou, Huiqing Chen, Mingjun Chen, Juanjuan Shi, Jianhua Jin, Qian Liu, Yongzhong Hou
Inhibition of CK2/ING4 Pathway Facilitates Non-Small Cell Lung Cancer Immunotherapy. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Qian Gou, Suning Che, Mingjun Chen, Huiqing Chen, Juanjuan Shi, Yongzhong Hou
PPARγ inhibited tumor immune escape by inducing PD-L1 autophagic degradation. Cancer science (2023)
Liuqian Xu, Suning Che, Huiqing Chen, Qian Liu, Juanjuan Shi, Jianhua Jin, Yongzhong Hou
PPARγ agonist inhibits c-Myc-mediated colorectal cancer tumor immune escape. Journal of cellular biochemistry (2023)
Qian Gou, Suning Che, Mingjun Chen, Huiqing Chen, Juanjuan Shi, Yongzhong Hou
PPARγ inhibited tumor immune escape by inducing PD-L1 autophagic degradation. Cancer science (2023)
Qian Gou, Suning Che, Mingjun Chen, Huiqing Chen, Juanjuan Shi, Yongzhong Hou
PPARγ inhibited tumor immune escape by inducing PD-L1 autophagic degradation. Cancer science (2023)
Deting Gong, Mingjun Chen, Yuhan Wang, Juanjuan Shi, Yongzhong Hou
Role of ferroptosis on tumor progression and immunotherapy. Cell death discovery 8 (1) (2022)
Yuyang Dai, Jinsong Liu, Xuyan Li, Jianzhong Deng, Cheng Zeng, Wenbin Lu, Yongzhong Hou, Ying Sheng, Honglin Wu, Qian Liu
Let-7b-5p inhibits colon cancer progression by prohibiting APC ubiquitination degradation and the Wnt pathway by targeting NKD1. Cancer science (2022)
Qian Gou, Chen Dong, Huihui Xu, Bibimaryam Khan, Jianhua Jin, Qian Liu, Juanjuan Shi, Yongzhong Hou
PD-L1 degradation pathway and immunotherapy for cancer. Cell death & disease 11 (11) (2020)
Qian Gou, Yidan Jiang, Runyun Zhang, Ying Xu, Huihui Xu, Wenbo Zhang, Juanjuan Shi, Yongzhong Hou
PPARδ is a regulator of autophagy by its phosphorylation. Oncogene 39 (25) (2020)
Qian Gou, Wenbo Zhang, Ying Xu, Jianhua Jin, Qian Liu, Yongzhong Hou, Juanjuan Shi
EGFR/PPARδ/HSP90 pathway mediates cancer cell metabolism and chemoresistance. Journal of cellular biochemistry 122 (3-4) (2020)
Mengli You, Jiaming Gao, Jianhua Jin, Yongzhong Hou
PPARα Enhances Cancer Cell Chemotherapy Sensitivity by Autophagy Induction. Journal of oncology 2018 (2018)
Shuping Yuan, Jianhua Jin, Lu Chen, Yongzhong Hou, Hong Wang
Naoxintong/PPARγ Signaling Inhibits Cardiac Hypertrophy via Activation of Autophagy. Evidence-based complementary and alternative medicine : eCAM 2017 (2017)
Huimin Xu, Jianhua Jin, Lu Chen, Chunxiao Li, Qinggang Xu, Juanjuan Shi, Buchang Zhao, Yongzhong Hou, Hong Wang
Naoxintong/PPARα Signaling Inhibits H9c2 Cell Apoptosis and Autophagy in Response to Oxidative Stress. Evidence-based complementary and alternative medicine : eCAM 2016 (2016)

Yongzhong Hou.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yongzhong Hou